BC cells were treated with macrophage-derived exosomes, upregulated/downregulated exosomal miR-503-3p, or silenced/overexpressed DACT2 to investigate the effects of altered miR-503-3p and DACT2 on BC development. This evidence concerns the gene DACT2 and breast cancer.